Carbonic Anhydrase I as a New Plasma Biomarker for Prostate Cancer

Figure 1

(a) Two-dimensional display of all MS peaks. The 117 MS peaks whose mean intensities significantly differed between prostate cancer patients and healthy controls (𝑃<0.05, Welch’s 𝑡-test) are highlighted in red. RT: retention time. (b) 2DICAL images of peak ID 396 in a representative prostate cancer patient (left) and a healthy control (right).

(a)

(b)